Cepon - Centro de Pesquisas Oncolăgicas de Santa Catarina

Florianópolis 88034-000

3 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer, Small Cell Lung Cancer

Studies at this site

• Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now
• A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer — Recruiting now
• Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer — Recruiting now
• Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) — Completed